Biotech Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction January 19, 2021
Biotech Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement January 19, 2021
Biotech Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis January 19, 2021
Biotech miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team January 19, 2021
Biotech Rosen, Leading Trial Attorneys, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action – FBIO January 18, 2021
Biotech JANUARY 26 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 18, 2021
Biotech Celyad Oncology Presents Data Update from Phase 1 alloSHRINK Trial for CYAD-101 in mCRC at ASCO-GI Symposium January 18, 2021
Biotech ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV January 16, 2021
Search
Biotech
January 19, 2021
January 19, 2021
January 19, 2021
January 19, 2021
January 19, 2021
January 19, 2021
January 18, 2021
January 18, 2021
January 18, 2021
January 16, 2021
